Pan-cancer analysis of the mediator complex transcriptome identifies CDK19 and CDK8 as therapeutic targets in advanced prostate cancer

Purpose: The Mediator complex is a multiprotein assembly, which serves as a hub for diverse signaling pathways to regulate gene expression. Because gene expression is frequently altered in cancer, a systematic understanding of the Mediator complex in malignancies could foster the development of nove...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Brägelmann, Johannes (VerfasserIn) , Duensing, Stefan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: April 2017
In: Clinical cancer research
Year: 2016, Jahrgang: 23, Heft: 7, Pages: 1829-1840
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-16-0094
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1158/1078-0432.CCR-16-0094
Verlag, kostenfrei, Volltext: http://clincancerres.aacrjournals.org/content/23/7/1829
Volltext
Verfasserangaben:Johannes Brägelmann, Niklas Klümper, Anne Offermann, Anne von Mässenhausen, Diana Böhm, Mario Deng, Angela Queisser, Christine Sanders, Isabella Syring, Axel S. Merseburger, Wenzel Vogel, Elisabeth Sievers, Ignacija Vlasic, Jessica Carlsson, Ove Andrén, Peter Brossart, Stefan Duensing, Maria A. Svensson, Zaki Shaikhibrahim, Jutta Kirfel, and Sven Perner

MARC

LEADER 00000caa a2200000 c 4500
001 1576272907
003 DE-627
005 20220814161145.0
007 cr uuu---uuuuu
008 180612r20172016xx |||||o 00| ||eng c
024 7 |a 10.1158/1078-0432.CCR-16-0094  |2 doi 
035 |a (DE-627)1576272907 
035 |a (DE-576)506272907 
035 |a (DE-599)BSZ506272907 
035 |a (OCoLC)1341011449 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Brägelmann, Johannes  |e VerfasserIn  |0 (DE-588)1053647247  |0 (DE-627)790416050  |0 (DE-576)409599506  |4 aut 
245 1 0 |a Pan-cancer analysis of the mediator complex transcriptome identifies CDK19 and CDK8 as therapeutic targets in advanced prostate cancer  |c Johannes Brägelmann, Niklas Klümper, Anne Offermann, Anne von Mässenhausen, Diana Böhm, Mario Deng, Angela Queisser, Christine Sanders, Isabella Syring, Axel S. Merseburger, Wenzel Vogel, Elisabeth Sievers, Ignacija Vlasic, Jessica Carlsson, Ove Andrén, Peter Brossart, Stefan Duensing, Maria A. Svensson, Zaki Shaikhibrahim, Jutta Kirfel, and Sven Perner 
264 1 |c April 2017 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online first September 27, 2016 
500 |a Gesehen am 12.06.2018 
520 |a Purpose: The Mediator complex is a multiprotein assembly, which serves as a hub for diverse signaling pathways to regulate gene expression. Because gene expression is frequently altered in cancer, a systematic understanding of the Mediator complex in malignancies could foster the development of novel targeted therapeutic approaches. Experimental Design: We performed a systematic deconvolution of the Mediator subunit expression profiles across 23 cancer entities (n = 8,568) using data from The Cancer Genome Atlas (TCGA). Prostate cancer-specific findings were validated in two publicly available gene expression cohorts and a large cohort of primary and advanced prostate cancer (n = 622) stained by immunohistochemistry. The role of CDK19 and CDK8 was evaluated by siRNA-mediated gene knockdown and inhibitor treatment in prostate cancer cell lines with functional assays and gene expression analysis by RNAseq. Results: Cluster analysis of TCGA expression data segregated tumor entities, indicating tumor-type-specific Mediator complex compositions. Only prostate cancer was marked by high expression of CDK19. In primary prostate cancer, CDK19 was associated with increased aggressiveness and shorter disease-free survival. During cancer progression, highest levels of CDK19 and of its paralog CDK8 were present in metastases. In vitro, inhibition of CDK19 and CDK8 by knockdown or treatment with a selective CDK8/CDK19 inhibitor significantly decreased migration and invasion. Conclusions: Our analysis revealed distinct transcriptional expression profiles of the Mediator complex across cancer entities indicating differential modes of transcriptional regulation. Moreover, it identified CDK19 and CDK8 to be specifically overexpressed during prostate cancer progression, highlighting their potential as novel therapeutic targets in advanced prostate cancer. Clin Cancer Res; 23(7); 1829-40. ©2016 AACR. 
534 |c 2016 
700 1 |a Duensing, Stefan  |d 1967-  |e VerfasserIn  |0 (DE-588)1074044487  |0 (DE-627)830213007  |0 (DE-576)435550098  |4 aut 
773 0 8 |i Enthalten in  |t Clinical cancer research  |d Philadelphia, Pa. [u.a.] : AACR, 1995  |g 23(2017), 7, Seite 1829-1840  |h Online-Ressource  |w (DE-627)325489971  |w (DE-600)2036787-9  |w (DE-576)094502234  |x 1557-3265  |7 nnas  |a Pan-cancer analysis of the mediator complex transcriptome identifies CDK19 and CDK8 as therapeutic targets in advanced prostate cancer 
773 1 8 |g volume:23  |g year:2017  |g number:7  |g pages:1829-1840  |g extent:12  |a Pan-cancer analysis of the mediator complex transcriptome identifies CDK19 and CDK8 as therapeutic targets in advanced prostate cancer 
856 4 0 |u http://dx.doi.org/10.1158/1078-0432.CCR-16-0094  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://clincancerres.aacrjournals.org/content/23/7/1829  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180612 
993 |a Article 
994 |a 2017 
998 |g 1074044487  |a Duensing, Stefan  |m 1074044487:Duensing, Stefan  |d 910000  |d 910200  |e 910000PD1074044487  |e 910200PD1074044487  |k 0/910000/  |k 1/910000/910200/  |p 17 
999 |a KXP-PPN1576272907  |e 3012508112 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Johannes Brägelmann, Niklas Klümper, Anne Offermann, Anne von Mässenhausen, Diana Böhm, Mario Deng, Angela Queisser, Christine Sanders, Isabella Syring, Axel S. Merseburger, Wenzel Vogel, Elisabeth Sievers, Ignacija Vlasic, Jessica Carlsson, Ove Andrén, Peter Brossart, Stefan Duensing, Maria A. Svensson, Zaki Shaikhibrahim, Jutta Kirfel, and Sven Perner"]},"id":{"doi":["10.1158/1078-0432.CCR-16-0094"],"eki":["1576272907"]},"origin":[{"dateIssuedDisp":"April 2017","dateIssuedKey":"2017"}],"relHost":[{"title":[{"title":"Clinical cancer research","title_sort":"Clinical cancer research"}],"pubHistory":["1.1995 -"],"part":{"text":"23(2017), 7, Seite 1829-1840","volume":"23","extent":"12","year":"2017","issue":"7","pages":"1829-1840"},"disp":"Pan-cancer analysis of the mediator complex transcriptome identifies CDK19 and CDK8 as therapeutic targets in advanced prostate cancerClinical cancer research","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 08.06.2023","Fortsetzung der Druck-Ausgabe"],"recId":"325489971","corporate":[{"role":"isb","display":"American Association for Cancer Research","roleDisplay":"Herausgebendes Organ"}],"language":["eng"],"origin":[{"publisherPlace":"Philadelphia, Pa. [u.a.]","dateIssuedDisp":"1995-","dateIssuedKey":"1995","publisher":"AACR"}],"id":{"eki":["325489971"],"zdb":["2036787-9"],"issn":["1557-3265"]},"name":{"displayForm":["American Association for Cancer Research"]},"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"12 S."}],"person":[{"family":"Brägelmann","given":"Johannes","display":"Brägelmann, Johannes","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Duensing, Stefan","role":"aut","family":"Duensing","given":"Stefan"}],"title":[{"title":"Pan-cancer analysis of the mediator complex transcriptome identifies CDK19 and CDK8 as therapeutic targets in advanced prostate cancer","title_sort":"Pan-cancer analysis of the mediator complex transcriptome identifies CDK19 and CDK8 as therapeutic targets in advanced prostate cancer"}],"language":["eng"],"recId":"1576272907","note":["Published online first September 27, 2016","Gesehen am 12.06.2018"],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a BRAEGELMANPANCANCERA2017